In the United States, the pharmaceutical intermediate manufacturing sector is undergoing a massive shift toward intensified processing. The geographic concentration of biotech hubs in Massachusetts and California requires specialized PFPE oil to handle extreme temperature fluctuations during synthesis while maintaining zero contamination.
Environmental regulations from the EPA have pushed US manufacturers away from traditional hydrocarbons toward more stable, non-flammable options. This has led to a surge in the adoption of Perfluoropolyether oil, which offers the necessary chemical inertness for reacting sensitive medicinal compounds without risking fluid degradation.
Furthermore, the integration of AI-driven drug discovery in the US has increased the reliance on high-performance computing. This has created a dual demand: high-purity chemicals for the lab and sophisticated heat transfer fluid for the data centers supporting these pharmaceutical computations.
